DOVER, DE, USA I6, 2024 I Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 ...

Following this initial assessment, proof-of-concept studies are planned for patients with idiopathic Parkinson's disease. Preclinical data underscores the potential of BT-267 as the best-in-class ...

Admitted to NIMHANS, the girl has been diagnosed with idiopathic dystonia, a movement disorder. With an expensive Deep Brain Stimulation (DBS) surgery as the only option, her family is now seeking ...

Sudden cardiac arrest and death occur among competitive and recreational athletes across the entire spectrum of age, sex, and ...

Idiopathic Parkinson’s disease (IPD) is a central nervous system disorder affecting the basal ganglia that is caused by death of dopamine-producing cells in the substantia nigra. Although IPD is ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Cassava Sciences' Phase 3 trial for Alzheimer's failed to meet primary or secondary endpoints, leading to the discontinuation ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

As Del Amitri begin a tour of Scotland, singer songwriter Justin Currie reveals how his Parkinson’s diagnosis has brought the ...